{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Anorexia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Confusion"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Dehydration"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Diarrhea"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}],"title":"Dyspnea (shortness of breath)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"}]}],"title":"Fatigue (asthenia, lethargy, malaise)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}],"title":"Glucose, serum-high (hyperglycemia)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}],"title":"Hemoglobin"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"INR (of prothrombin time)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Inf (clin/microbio) w/Gr 3-4 neuts - Lung"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}],"title":"Infection with unknown ANC - Lung (pneumonia)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Left ventricular systolic dysfunction"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Lymphopenia"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Mucositis/stomatitis (clinical exam) - Oral cavity"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Mucositis/stomatitis (functional/symp) - Oral cav"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Muscle weakness, not d/t neuropathy - body/general"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Pneumonitis/pulmonary infiltrates"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Rash/desquamation"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Triglyceride, serum-high (hypertriglyceridemia)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"59"}],"units":"Participants"}],"groups":[{"description":"Daily oral Everolimus 10 mg/day","id":"OG000","title":"Everolimus"}],"paramType":"NUMBER","populationDescription":"Number of Subjects With Greater Than Grade 2 Toxicity","reportingStatus":"POSTED","timeFrame":"Weekly during the first 8 weeks of treatment, then every 4 weeks while on treatment, then every 8 weeks until disease progression, then every 6 months thereafter.","title":"Frequency and Severity of Toxicities","type":"SECONDARY","unitOfMeasure":"participants"}